NEW YORK, N.Y.—October 12, 2007
"What makes this study so surprising is that people and even doctors have always underestimated the prevalence of arthritis and its profound impact upon people in the prime of their active lives," said Stephen A. Paget, MD, FACP, FACR, physician-in-chief and chairman of the Division of Rheumatology, Hospital for Special Surgery. "This should be considered a 'call to arms' to spread the word about what common arthritis is and how it can dash the hopes of people with it."
Dr. Paget adds that, given the expanded life span and enlarging elderly population who want to continue to be productive and mobile people, there is an urgent need for further support for research into the causes of and cures for arthritis.
With the largest group of rheumatologists in the country, HSS is a world leader in the research and treatment of rheumatic disease.
If you would like to speak with Dr. Paget, please contact:
About Hospital for Special Surgery
Hospital for Special Surgery (HSS) is the world’s leading academic medical center focused on musculoskeletal health. HSS is nationally ranked No. 1 in orthopedics and No. 3 in rheumatology by U.S. News & World Report (2017-2018), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. HSS has one of the lowest infection rates in the country. HSS is an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. HSS has locations in New York, New Jersey and Connecticut.